baber/WOPTO huggingface dataset:
Patent NZ-505662-A (NZ)
Title: Visualisation of data representing web site visitor activity
Inventor: CARDNO ANDREW JOHN
IPC: G06Q30/02
Filed: 2000-07-10
Abstract: Data is presented for visualization by maintaining a discrete set of finite data values in a computer memory and displaying each data value centered on a respective data point, with a plurality of the data points being positioned in a circular array.  A contour generator generates and displays a contoured representation around each data point so that the data point is displayed as a local maximum.
Patent NZ-506633-A (NZ)
Title: Process for making tetrahydro-4-[3-(4-fluorophenyl)thio]phenyl-2H-pyran-4-carboxamide
Inventor: NORRIS TIMOTHY
IPC: A61K31/41
Filed: 2000-08-30
Abstract: A process is described for preparing a compound of Formula (1.3.0) comprising establishing a reaction mixture consisting of Formula (2.0.0) and Formula (2.1.0) in aprotic solvent, in the presence of NaOH or KOH; optionally in the presence of a phase transfer catalyst, especially a quaternary ammonium salt or phosphonium salt; followed by heating the reaction mixture under nitrogen atmosphere. In the preferred embodiment the aprotic solvent is DMSO, the strong base in solid form is NaOH in powder or pellet form, and the phase transfer catalyst is tetra-n-butylammonium chloride (TBAC); wherein the starting material of Formula (2.0.0) is prepared by reacting together Formula 3.1.0) and (4.0.0) in a solvent consisting of a straight or branched chain aliphatic alcohol; in the presence of strong base consisting of NaOH or KOH; further in the presence of a transition metal catalyst comprising a palladium metal complex; and still further in the presence of an auxiliary ligand comprising a bidentate, chiral, axially dissymmetric aromatic compound of Formula (5.0.0).
Patent NZ-511540-A (NZ)
Title: Neisseria genomic sequences and methods of their use
Inventor: GALEOTTI CESIRA
IPC: C12N15/11
Filed: 1999-10-08
Abstract: Disclosed is an immunogenic protein from Neisseria, including the corresponding nucleotide sequence. The proteins so obtained are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.
Patent NZ-511740-A (NZ)
Title: Shuttle granulator
Inventor: MAGUIRE STEPHEN B
IPC: B29B17/04
Filed: 1999-04-06
Abstract: Apparatus for reducing large pieces of solid plastic material to smaller size for recycling, comprising: a) a longitudinally elongated table having transversely displaced upper and lower segments; b) a cutter between said upper and lower table segments; c) a movable hopper for receiving said large plastic pieces to be size-reduced having an open bottom through which said plastic pieces may contact said table; and d) means for supporting and moving said hopper between upper and lower table segments.
Patent NZ-515423-A (NZ)
Title: Compositions and uses of ET743 for treating cancer
Inventor: MISSET JEAN LOUIS
IPC: C07D515/22
Filed: 2000-05-15
Abstract: The use of ET743 in the preparation of a medicament for the treatment of the human body for cancer is disclosed, wherein the ET743 is formulated to be suitable for intravenous administration at a dosage of 500 to 1650 micrograms/m2 for cycles of intravenous infusion at intervals of 1 to 6 weeks.
Patent NZ-515704-A (NZ)
Title: Method and apparatus for treating gas for delivery to an animal
Inventor: OTT DOUGLAS E
IPC: A61M31/00
Filed: 2000-05-17
Abstract: This invention is a method, and apparatus (100) for treating gas for delivery into a body cavity, body space or body surface of an animal. The apparatus (100) comprises a housing (122) defining a chamber (128) having an entry port (124), and an exit port (126). One or more agents are released into the gas stream that flows through the chamber (128) so that the gas stream carries the agent to the animal.
Patent NZ-519234-A (NZ)
Title: Method for producing metabolites from plants cultivated in soil-less medium
Inventor: GONTIER ERIC
IPC: A01G31/00
Filed: 2000-11-07
Abstract: Method of producing molecules from plants, characterised in that said plants are cultivated in soil- less conditions and are fed with a nutrient solution and/or are sprayed with a leaching liquid, said solution and/or said liquid then being recovered and treated to extract therefrom certain predetermined molecules that it contains and which have been liberated by the plant roots and/or top growth.
Patent NZ-520380-A (NZ)
Title: Process of forming a refrigerated dough incorporating a cereal endogenous xylanase inhibitor in the mixture
Inventor: POULSEN CHARLOTTE HORSMANS
IPC: A21D13/00
Filed: 2001-01-17
Abstract: Use of a cereal endogenous xylanase inhibitor in the production of refrigerated dough, said protein reducing the enzymatic degradation of arabinoxylan and preventing syruping.
Patent NZ-521231-A (NZ)
Title: Improvements in and relating to training ammunition
Inventor: SAXBY MICHAEL ERNEST
IPC: F42B8/02
Filed: 2001-02-08
Abstract: The invention provides a training cartridge (304) having a peripheral fire primer (306) and a gun modified to fire the cartridge. The combination of modified gun and peripheral fire cartridge avoids the potentially adverse consequences that could arise if live ammunition and training ammunition were to become inadvertently confused or mixed up by preventing the firing of live centre fire ammunition.
Patent NZ-528418-A (NZ)
Title: Information recordal
Inventor: MARSHALL FELICITY RUTH
IPC: G06F19/00
Filed: 2003-11-04
Abstract: A method of processing electronic data generated by at least one user comprises: (i) receiving the electronic data in a first format including an indication of a user's current height and weight; (ii) associating an identifier with the data when in the first format, (iii) transmitting the identifier and the electronic data when in the first format to a storage means, (iv) manipulating the data in the first format to indicate an user's predicted height at a specific period in the future and predicting the user's weight at that specific time in the future; v) calculating a specific length of time for a user to maintain a constant weight and v) displaying the specific length of time on a display means.
Patent NZ-531436-A (NZ)
Title: A glutaraldehyde composition
Inventor: MARTIN ANTONIETTA PAMELA
Filed: 2002-07-26
Abstract: Disclosed is a stable aqueous glutaraldehyde solution including: a 0.005% to 45% m/v solution of glutaraldehyde (OCH(CH2)3CHO); an alcohol ethoxylate non-ionic surfactant; sodium acetate trihydrate (NaC2H3O2); and sufficient amount of a pH modifier to bring the pH of the solution to 6.0 to 8.5; wherein the glutaraldehyde is complexed to the alcohol ethoxylated non-ionic surfactant. Also disclosed is a method of producing the stable aqueous glutaraldehyde solution.
Patent NZ-533340-A (NZ)
Title: A juice concentration process
Inventor: RUSSELL RONALD WILLIAM
Filed: 2004-08-05
Abstract: Disclosed is a process for treating a fruit, vegetable or vegetable plant matter juice including the steps of: a) filtering the juice, b) removing water from the filtered juice to concentrate the proteins and other beneficial nutrients in the juice to form a concentrate, c) spray drying the concentrate from step b), wherein steps a) and b) are operated at substantially less than 20  C, and step c) is operated to achieve a predetermined agglomerated particle size.
Patent NZ-533674-A (NZ)
Title: Method and system for simultaneously imaging multiple views of a plant embryo
Inventor: HIRAHARA EDWIN
IPC: G06T15/00
Filed: 2004-06-21
Abstract: A method of simultaneously imaging multiple views of a plant embryo, consists of: providing a camera for receiving a first view of a plant embryo; providing a first reflecting surface for receiving and reflecting a second view of the plant embryo toward the camera; and using the camera, simultaneously imaging the first and second views of the plant embryo.
Patent NZ-535995-A (NZ)
Title: System and apparatus for compressing and decompressing data stored to a portable data storage device
Inventor: POO TENG PIN
IPC: G06F13/12
Filed: 2002-05-13
Abstract: A unitary portable data storage device (100) is disclosed. The portable data storage device (100) includes a universal serial bus (USB) connector (40) adapted to the storage device (100), whereby the device (100) is capable of being directly connected to a computer via the connector (40) to receive data in the form of data packets. The storage device (100) includes a flash memory (180) which has a first storage capacity, and a data compression engine (190). The data compression engine (190) is capable of compressing each of the data packets to form respective compressed data in the form of data packets for storage in the flash memory (180), so that the capacity of the flash memory (180) exceeds the first storage capacity.
Patent NZ-539019-A (NZ)
Title: Products and methods for treating vaginal infections
Inventor: HUTMAN HERBERT W
IPC: A61K31/4178
Filed: 2005-03-23
Abstract: Disclosed herein is a use of an anti-fungal and/or anti-bacterial active ingredient in the manufacture of a solid dosage form, comprising an anti-fungal or anti-bacterial effective amount of the anti-fungal or anti bacterial active ingredient, for the treatment of a vaginal infection in a patient in need thereof, wherein the solid dosage form is suitable for insertion into the vagina at any time after the patient awakens until thirty minutes prior to the patient retiring for the night and for retention in the vaginal cavity throughout the treatment. The solid dosage form may be a solid gelatin capsule, or a suppository. The anti-fungal active ingredient is preferably miconazole nitrate, and the anti-bacterial active ingredient is preferably metronidazole. An external cream containing an anti-fungal or anti-bacterial active ingredient may also be applied at least once per day for at least five days after insertion of said solid dosage form. Vigorous movement subsequent to inserting the solid dosage form is advantageous in the treatment. Such compositions may also comprise one or more probiotics. Also disclosed are solid dosage forms comprising an anti-viral agent. Each of the compositions above may be used to treat an infection of a body cavity in general.
Patent NZ-539892-A (NZ)
Title: Pump using an adjustable buoyancy block driven by wave motion to displace a fluid
Inventor: WELCH KENNETH W
IPC: F03B13/18
Filed: 2003-10-10
Abstract: Various embodiments of buoyancy pumps (100) that can be used to displace a fluid to drive a turbine for power generation are disclosed. The pump has a buoyancy block (114) with adjustable buoyancy reciprocally moving in response to wave action. A piston (120) within a cylinder (108) is connected to the buoyancy block. The motion of the piston is used to draw an operating fluid into the cylinder and then force it out.
Patent NZ-542396-A (NZ)
Title: Novel method for the synthesis of S-indoline-2-carboxylic acid and application thereof in the synthesis of perindopril
Inventor: SOUVIE JEAN-CLAUDE
IPC: C07B57/00
Filed: 2004-04-07
Abstract: Disclosed is a process for the synthesis of (2S)-indoline-2-carboxylic acid of formula (I), characterised by reacting racemic indoline-2-carboxylic acid with a chiral amine to yield a salt with the chiral amine, which is filtered off, and there being isolated: the (2S) isomer of the chiral amine salt in the form of crystals, which is then treated with hydrochloric acid to yield the compound of formula (I), and a mixture of the (2S) isomer of the chiral amine salt and the (2R) isomer of the chiral amine salt in which the (2R) isomer of the chiral amine salt predominates, by evaporation of the filtrate, which mixture is then treated with hydrochloric acid to yield a mixture of (2R)-indoline-2-carboxylic acid and (2S)-indoline-2-carboxylic acid in which the (2R) acid predominates, which is racemised by reaction with sodium hydroxide solution at a temperature of from 140 to 200 deg C, under a pressure of from 5 to 15 bars, to yield, after isolation, racemic indoline-2-carboxylic acid, with which the series of operations described above is repeated, then, after having carried out from 2 to 6 cycles, all the portions made up of the compound of formula (I) are combined. Also disclosed is a process for the synthesis of (2S)-indoline-2-carboxylic acid of formula (I), characterised by racemizing (2R)-indoline-2-carboxylic acid with sodium hydroxide solution, at a temperature of from 140 to 200øC, under a pressure of from 5 to 15 bars, to yield racemic indoline-2-carboxylic acid, which is reacted with a chiral amine to yield a salt with the chiral amine, which is filtered off, and there being isolated : the (2S) isomer of the chiral amine salt in the form of crystals, which is then treated with hydrochloric acid to yield the compound of formula (I), a mixture of the (2S) isomer of the chiral amine salt and the (2R) isomer of the chiral amine salt in which the (2R) isomer the chiral amine salt predominates, by evaporation of the filtrate, which mixture is then treated with hydrochloric acid to yield a mixture of (2R)-indoline-2-carboxylic acid and (2S)-indoline-2-carboxylic acid in which the (2R) acid predominates, then, after having carried out from 1 to 6 cycles of the process, all the portions made up of the compound of formula (I) are combined.
Patent NZ-551430-A (NZ)
Title: Diagnosing or predicting the course of breast cancer
Inventor: ATKINS DAVID
IPC: G01N33/574
Filed: 2005-06-06
Abstract: Provided is a method of diagnosing the presence or predicting the course of breast cancer comprising measuring the expression of a combination of marker genes comprising at least one tissue specific gene and at least one non-tissue-specific gene in a cell or tissue sample derived from a patient; wherein the tissue-specific gene is selected from the group consisting of mammaglobin, PIP and B30SD, and the non-tissue specific gene is selected from the group consisting of CK19 and EPCAM. Further provided are corresponding PCR primer kits for said assays.
Patent NZ-552172-A (NZ)
Title: Topical antiviral formulations comprising [2-(6-amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid diisopropoxycarbonyloxymethyl ester (tenofovir)
Inventor: DAHL TERRENCE C
IPC: A61K9/06
Filed: 2005-07-01
Abstract: Disclosed is a pharmaceutical vaginal gel comprising [2-(6-amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid diisopropoxycarbonyloxymethyl ester or a physiologically acceptable salt thereof, hydroxyethylcellulose, propylparaben, methylparaben, edetate disodium, glycerin, citric acid and purified water. Also disclosed is a condom coated with the above formulation.
Patent NZ-556242-A (NZ)
Title: An encapsulated edible fibre product having controlled water absorbtion
Inventor: CUDIA ARIEL
IPC: A23L7/10
Filed: 2005-12-21
Abstract: Disclosed is an encapsulated edible fiber product having controlled water absorption, said encapsulated edible fiber product comprising substantially unswollen edible fiber particles (such as celluloses, raw starches, modified starches, glucans, brans, hydrocolloids, xanthans, algins, alginate salts, pectins, guars, chitosan and mixtures thereof) having an outer surface, wherein at least about 80% of the outer surface of the edible fiber particles is covered with an inner layer comprising an edible fat or lipid (such as a low- or reduced-calorie triglyceride or blends thereof having one or two short chain fatty acids and one or two long chain saturated fatty acids, and which have a melting point of about 30 to about 40°C); at least about 90% of the inner layer is covered with an outer layer comprising a edible protein (such as casein, zein, soy isolate, milk protein concentrate, whey protein concentrate and mixtures thereof); the inner and outer layers provide an effective moisture barrier to prevent significant swelling of the edible fiber particles due to moisture absorption during processing, storage, and initial stages of digestion by a human; and the moisture barrier is breached during later stages of digestion so that the edible fiber particles swell due to moisture absorption.
Patent NZ-562749-A (NZ)
Title: Directed complementation
Inventor: ROBINSON MURRAY
IPC: C12N15/85
Filed: 2006-04-05
Abstract: Provided is a method of producing primary tumor material, the tumorigenicity of which depends on a recombinant human gene of interest, comprising the steps of: (a) providing a conditionally tumorigenic mouse cell comprising (i) one or more mutations such that both alleles of an endogenous tumor suppressor gene are absent or non-functional, and (ii) a recombinant oncogene operably linked to an inducible promoter, wherein (l) tumorigenicity of the conditionally tumorigenic mouse cell is dependent upon expression of the inducible recombinant oncogene, and (2) the inducible promoter is in the uninduced state; and (b) introducing into the cell a recombinant human gene of interest that functionally complements the recombinant oncogene; (c) introducing the cell of step (b) into an immunocompromised recipient mouse; (d) maintaining the recipient mouse for a suitable tumor latency period, in the absence of an inducer of the inducible promoter; and (e) harvesting primary tumor material from the directed complementation tumor.
Patent NZ-571989-A (NZ)
Title: Antimicrobial protein
Inventor: COCKS BENJAMIN
IPC: A61P31/10
Filed: 2007-03-23
Abstract: Disclosed is an antimicrobial peptide fragment of a tammar wallaby milk protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-7, 18, 19, and 30-35 or an antimicrobial derivative or analog thereof comprising an amino acid sequence selected from SEQ ID NOs: 1-7, 18, 19 and 30-35 wherein one or more amino acid residues are D amino acid residues or said sequence is reversed or said sequence is retroinverted, and wherein said peptide fragment, derivative or analog has enhanced activity against one or a plurality of gram-negative bacteria relative to an equivalent amount of LL-37 peptide comprising amino acid residues 104-140 of the 18-10a human cationic antimicrobial protein (hCAP18) as determined by a minimal inhibitory concentration (MIC) assay. Also disclosed is the use of the peptides in the preparation of a medicament for reducing or preventing microbial growth.
Patent NZ-572201-A (NZ)
Title: Inhibitors of c-fms kinase
Inventor: ILLIG CARL R
IPC: C07D407/12
Filed: 2007-04-18
Abstract: Disclosed are compounds of Formula I or a tautomer or pharmaceutically acceptable salt thereof, wherein W is selected from one of the structures depicted and the remaining substituents are as defined in the specification. Also disclosed are their use as protein tyrosine kinase inhibitors, in particular c-fms kinase inhibitors, and their use in treating inflammation, cancer and cardiovascular disease.
Patent NZ-574307-A (NZ)
Title: Middleware broker
Inventor: SLAMKOVIC RICHARD
IPC: H04L29/08
Filed: 2007-06-21
Abstract: A protocol-level middleware inter-operability system supporting a wide range of communication protocols, including legacy systems is disclosed. The middleware inter-operability system has an input for receiving communication message in a communication protocol; a repository and a broker. General rules and middleware characteristics are specified in the repository to provide the connection and transformation for middleware protocols and for legacy systems to allow exchange of the communication message. The broker reviews all data structures, regardless of complexity, as being comprised of a finite set of primitive data types and with reference to the repository determines a mechanism for reading and writing these types to enable processing of structures of arbitrary complexity. The rules and mechanisms for reading these basic types are defined by the protocol and once the rules are captured allow processing and exchange of any communication message over this protocol. The broker uses a modified IDL style language (Protocol Definition Language or PDL) to define protocols. The PDL definition is compiled into a set of binary op-codes known as a Protocol Implementation Module (PIM) and the op-codes in the PIM contain instructions for traversing the interface definitions stored in the repository with the definitions obtained by parsing the IDL description for the interface and include a Dynamic Adaptive Marshaller (DAM) which is a virtual machine, which loads and executes the op-codes in the PIM at runtime. The middleware inter-operability system further has a dynamic marshaller for the conversion based on the rules determined by the broker due to the relevant structure format correlations to allow ready flow of data from one input protocol to be readable by output protocol and an output in a language neutral machine independent definition language specifying the structure of communication messages and the parameter templates to establish a connection and to exchange the communication messages. The system provides the interface definitions of the selected communication protocol and allows the communication messages to be sent and understood at the receiver and further allows new protocol support to be added without impact on existing systems and without re-compilation of application software. Further disclosed is a method of intercommunication across communication protocols using the above described system.
Patent NZ-575225-A (NZ)
Title: A blocking piece load distributing member, for road barrier, having planar outer surface and inward projection to fit in blocking piece
Inventor: WALLACE HAYDEN
IPC: E01F15/00
Filed: 2006-09-19
Abstract: A road barrier blocking piece load distributor, typically being provided as each of a pair 58.1 and 58.2, has an L-shaped construction, with a planar front portion so as to provide a load distributing surface and an attachment portion projecting rearwardly so as to fit within a preformed recess of a blocking piece. The attachment portion has a width less than that of the front planar portion and the front planar portion projects beyond the attachment portion in the plane of the load distributing surface. Typically the load distributor is formed in the moulded blocking piece.
Patent NZ-575863-A (NZ)
Title: Improvements in and relating to wall panels
Inventor: RANSOM NICHOLAS CHARLES
IPC: E04G11/06
Filed: 2007-09-18
Abstract: A wall assembly includes a resilient panel 1 and top and bottom concrete beams 106, 108 positioned near the top and bottom edges of the panel. The panel includes vertically running projections 2 spaced apart along the length of the panel and on the inside (concrete) side of the panel, and the concrete beams are formed by pouring concrete between the projections. (62) Divided Out of 561622
Patent NZ-585142-A (NZ)
Title: Imidazole compounds that inhibit kinesin spindle protein (KSP or Eg5)
Inventor: ABRAMS TINYA
IPC: A61P35/00
Filed: 2008-12-12
Abstract: Disclosed is a benzyl protected imidazole compound of formula (II) e.g. (S)-N-((S)-3-amino-4-fluorobutyl)-N-((R)-1-(1-benzyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)-2,2-dimethylpropyl)-2-hydroxypropanamide wherein the substituents are defined in the specification or a pharmaceutically acceptable salt thereof for the treatment of a proliferative disease selected from a solid tumor and a hematological cancer
Patent NZ-587924-A (NZ)
Title: Herbicidal compounds
Inventor: MITCHELL GLYNN
IPC: A01P13/00
Filed: 2009-03-16
Abstract: Disclosed herein are herbicidal [1,8]-naphthyridine compounds of formula Ia and Ib wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof in controlling weeds, in particular in crops of useful plants or for inhibiting plant growth.